System-based drug discovery within the human kinome.

作者: Paul Bamborough

DOI: 10.1517/17460441.2012.724056

关键词:

摘要: Introduction: For well over a decade, significant effort has been devoted to the search for inhibitors of human protein kinase family. This is increasingly translating into success in clinic, with five new inhibitor drugs approved since 2011. However, despite encouraging signs other areas, largely restricted oncology. Areas covered: article reviews prospects drug discovery oncology and therapeutic areas. Major topics include application kinome profiling lessons learned from system-based research. With these fields nearing maturity, validation kinases as targets or their classification liabilities becoming pertinent. Other discussion properties required good small molecule probes. Expert opinion: The tractability through research excellent, adequate selectivity can often be achieved. With...

参考文章(138)
Jim R Woodburn, Susan E Ashton, Simon P Guy, Keith H Gibson, Brenda J Curry, Andrew J Barker, Alan E Wakeling, ZD1839 (Iressa): an orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Research. ,vol. 62, pp. 5749- 5754 ,(2002)
John T. Lee, Ling Li, Patricia A. Brafford, Marcia van den Eijnden, Molly B. Halloran, Katrin Sproesser, Nikolas K. Haass, Keiran S.M. Smalley, James Tsai, Gideon Bollag, Meenhard Herlyn, PLX4032, a potent inhibitor of the B-Raf V600E oncogene, selectively inhibits V600E-positive melanomas. Pigment Cell & Melanoma Research. ,vol. 23, pp. 820- 827 ,(2010) , 10.1111/J.1755-148X.2010.00763.X
Joost CM Uitdehaag, Folkert Verkaar, Husam Alwan, Jos de Man, Rogier C Buijsman, Guido JR Zaman, A guide to picking the most selective kinase inhibitor tool compounds for pharmacological validation of drug targets British Journal of Pharmacology. ,vol. 166, pp. 858- 876 ,(2012) , 10.1111/J.1476-5381.2012.01859.X
Vincent A. Pollack, Catherine DiOrio, April Theleman, Elsa G. Barbacci, Leslie R. Pustilnik, Mark Neveu, Mikel P. Moyer, Kenneth K. Iwata, Lee Arnold, Michael J. Morin, James D. Moyer, Bruce Boman, Penny Miller, Ann Cunningham, Margaret M. Reynolds, Don Sloan, Jonathan Doty, Induction of Apoptosis and Cell Cycle Arrest by CP-358,774, an Inhibitor of Epidermal Growth Factor Receptor Tyrosine Kinase Cancer Research. ,vol. 57, pp. 4838- 4848 ,(1997)
J. M. Stommel, A. C. Kimmelman, H. Ying, R. Nabioullin, A. H. Ponugoti, R. Wiedemeyer, A. H. Stegh, J. E. Bradner, K. L. Ligon, C. Brennan, L. Chin, R. A. DePinho, Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies Science. ,vol. 318, pp. 287- 290 ,(2007) , 10.1126/SCIENCE.1142946
John L. LaMattina, The impact of mergers on pharmaceutical R&D Nature Reviews Drug Discovery. ,vol. 10, pp. 559- 560 ,(2011) , 10.1038/NRD3514
Yekaterina Y. Zaytseva, Joseph D. Valentino, Pat Gulhati, B. Mark Evers, mTOR inhibitors in cancer therapy Cancer Letters. ,vol. 319, pp. 1- 7 ,(2012) , 10.1016/J.CANLET.2012.01.005
S Morgan-Lappe, K W Woods, Q Li, M G Anderson, M E Schurdak, Y Luo, V L Giranda, S W Fesik, J D Leverson, RNAi-based screening of the human kinome identifies Akt-cooperating kinases: a new approach to designing efficacious multitargeted kinase inhibitors. Oncogene. ,vol. 25, pp. 1340- 1348 ,(2006) , 10.1038/SJ.ONC.1209169
Paul Bamborough, Murray J. Brown, John A. Christopher, Chun-wa Chung, Geoff W. Mellor, Selectivity of Kinase Inhibitor Fragments Journal of Medicinal Chemistry. ,vol. 54, pp. 5131- 5143 ,(2011) , 10.1021/JM200349B
James D Griffin, Interaction maps for kinase inhibitors. Nature Biotechnology. ,vol. 23, pp. 308- 309 ,(2005) , 10.1038/NBT0305-308